Billing and Coding: Irreversible Electroporation for Cancer

This policy (A60221) contains billing and coding guidelines that complement Local Coverage Determination DL40205 for irreversible electroporation for cancer. The document as provided does not list specific clinical indications, limitations, frequency limits, or documentation requirements beyond referencing LCD DL40205; reviewers should consult DL40205 for detailed coverage criteria and perform manual review of the full policy text.

"This article provides billing, coding, and guideline information that complements the Local Coverage Determination DL40205 for Irreversible Electroporation for Cancer; refer to LCD DL40205 for clin..."

Sign up to see full coverage criteria, indications, and limitations.